Laboratorios Leon Farma S.A.

• Comparative Bioavailability of Levonorgestrel 52 mg Intrauterine System versus Mirena® in Healthy Pre-Menopausal, Non-Pregnant Female Partic… Recruiting
  2025-523736-39-00 1 country
• Bioequivalence of Testosterone Transdermal Gel in Healthy Female Participants. Ended
  2025-523300-77-00 1 country
• Multiple-Ascending Doses of 2-Methoxyestradiol in Healthy Non-Pregnant Female Participants. Ended
  2025-523419-12-00 Phase I (Other) 1 country
• Bioequivalence of Etonogestrel 68 mg Implant in Healthy Pre-Menopausal, Non-Pregnant Female Participants. Ended
  2025-520737-23-00 1 country
• Bioequivalence of Etonogestrel 68 mg Implant in Healthy Pre-Menopausal, Non-Pregnant Female Participants. Ended
  2025-520736-41-00 1 country
• Single-Ascending Doses of 2-Methoxyestradiol in Healthy Non-Pregnant Female Subjects. Ended
  2024-516854-23-00 Phase I 1 country
• Bioequivalence of Progesterone Vaginal Insert 100 mg in Healthy Pre-Menopausal, Nonpregnant Female Subjects. Ended
  2022-502614-82-00 1 country
• Bioequivalence of Ulipristal 30 mg Tablets in Healthy Subjects Under Fed Conditions Ended
  2023-504259-29-00 1 country
• Bioequivalence of Ulipristal 30 mg Tablets in Healthy Subjects Under Fasting Conditions Ended
  2023-504258-36-00 1 country ULIPRISTAL ACETATE
• Bioequivalence of Etonogestrel 68 mg Implant in Healthy Pre-Menopausal, Nonpregnant Female Subjects. Ended
  2023-504523-83-00 1 country
• Bioequivalence of Etonogestrel 68 mg Implant in Healthy Pre-Menopausal, Nonpregnant Female Subjects. Ended
  2023-504527-40-00 1 country
• Bioequivalence of Testosterone Transdermal Gel in Healthy Female Subjects Ended
  2022-501514-56-00 1 country TESTOSTERONE

Showing 1–12 of 12 trials